Skip to main content
Toggle navigation
Search
Home
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Rate ePoster
12 Views
View ePoster
Favorite
Tweet
Print
Email
PDF
(WHS-P46) IDENTIFICATION OF AKR101 AS POTENTIAL NEW DRUG FOR CHRONIC WOUND THERAPY
Friday, April 10, 2026
7:30 PM - 8:30 PM
ET
Gabriela C. Cabral1, Nicole Schöfmann1, Petra Dörfler1, Anton Stütz1, Barbara Wolff-Winiski1
1. Akribes Biomedical GmbH, Vienna, Other (Non US), Austria.